Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL We conducted a randomized trial of NeuroCARE versus usual care in PMBT caregivers with ...
In our study, caregivers in the age group of 35–49 years perceived significantly higher impact in terms of disrupted schedule and affected health as compared to caregivers between 21 and 34 years old.
PRODIGE 29-UCGI 26 (NEOPAN): A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma We conducted a randomized controlled trial of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results